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Human Rights in the Fourth Decade of the HIV/AIDS 
Response: An Inspiring Legacy and Urgent Imperative
jamie enoch and peter piot
Abstract
More than 35 years since the HIV/AIDS pandemic began, HIV continues to cause almost two million 
new infections each year, and the “end of AIDS” by 2030 remains elusive.1 Violations of human rights 
continue to fuel high rates of new infections among key populations and a generalized epidemic in 
much of sub-Saharan Africa. Meanwhile, as political shifts worldwide threaten not only HIV funding 
but also progress toward the globalization of human rights, civil society mobilization and advocacy 
founded firmly on human rights principles have a more vital role to play than ever. Encouragingly, 
there are numerous examples of successful integration of human rights-based approaches into HIV 
prevention and treatment initiatives, and evidence increasingly demonstrates that norms enshrining 
the respect, protection, and fulfillment of human rights can translate into improved public health.2 This 
essay will succinctly trace the historic emergence of human rights as an issue at the heart of the HIV/
AIDS response; it will then provide examples of progress and setbacks in recent years and consider the 
potential for rights promotion to address the structural drivers of HIV. Finally, it will consider how the 
primacy of human rights in HIV/AIDS has affected other fields of global health and will highlight the 
continuing imperative to work with civil society to protect and promote human rights to reduce the 
burden of HIV/AIDS. 
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Historical context of human rights in the 
HIV/AIDS response
The human rights discourse gained prominence in 
the early days of the epidemic in North America 
(and soon afterward in Brazil and Western Europe). 
In the face of authorities’ neglect of the epidemic, 
many people living with HIV (PLHIV) became 
advocates for their right to health and, in the case 
of the LGBT+ community, their right to non-dis-
crimination. The initial response by authorities in 
many countries was to stigmatize groups perceived 
to be high risk, such as men who have sex with 
men (MSM) and Haitian immigrants in the United 
States, and sex workers and truck drivers in India.3 
The marginal status and lack of political capital of 
many of those initially affected by HIV frequent-
ly allowed authorities to adopt a “law and order” 
response limiting individuals’ rights—for example, 
restricting PLHIV from international travel and 
employment. This climate of fear, blaming, sham-
ing, and isolation led groups most affected by the 
early HIV epidemic to mobilize against the inter-
locking stigma of living with HIV and being part 
of a minority group now associated with disease. 
Support and advocacy groups formed to demand 
that governments fund research, explore the po-
tential of experimental treatments, and provide 
prevention and communication materials. The 1983 
Denver Principles, for example, defined rights for 
“people with AIDS,” who refused to be considered 
“passive” victims or patients.4
In the global policy arena, the more formal 
linkage of health with human rights emerged 
thanks largely to the efforts of Jonathan Mann, the 
first director of the World Health Organization’s 
Global Programme on AIDS in the late 1980s.5 
Mann boldly framed AIDS as an issue of human 
rights and ethics, taking into account the broader 
social determinants and structural violence under-
lying the disease, in contrast to prevailing views of 
AIDS that focused on individuals’ risky or deviant 
behavior. While legal frameworks and mechanisms 
had frequently been used to protect the “general 
public” from the disease, Mann worked innova-
tively to utilize the law to protect people with the 
disease from discrimination and exclusion. He ar-
ticulated the epidemiological imperative for human 
rights, understanding that respecting the rights 
of PLHIV would improve their engagement with 
health programs, thereby enhancing HIV surveil-
lance and control. Mann’s advocacy work around 
the respect, protection, and fulfillment of rights for 
PLHIV helped drive major formal declarations and 
resolutions, such as the 1996 International Guide-
lines on HIV/AIDS and Human Rights.6 
Once HIV infection became a treatable con-
dition, access to antiretroviral therapy came to be 
framed as a human rights issue. This was ampli-
fied by legal disputes involving the governments 
of Brazil (where the United States had brought a 
World Trade Organization dispute settlement over 
TRIPS) and South Africa (where 39 pharmaceuti-
cal companies sued the government over changes 
to the law to expand access to generic drugs). The 
fight for access to HIV treatment represented a sig-
nificant advance in the justiciability of the right to 
health and has provided salutary examples of how 
social, economic, and cultural rights under the 
International Covenant on Economic, Social and 
Cultural Rights can be progressively realized.7 In 
Brazil, thanks in large part to rights-based mobi-
lization and activism, the government passed a law 
in 1996 to provide free universal access to antiretro-
virals, helping realize the government’s obligation 
under the Brazilian Constitution to fulfill the right 
to health. In South Africa, the 2002 litigation of 
the Treatment Action Campaign and the AIDS 
Law Project, regarding the government’s failure 
to provide pregnant women with nevirapine and 
thus prevent HIV transmission to their children, 
has become an exemplar of how civil society can 
hold governments accountable for their obligation 
to fulfill the right to health.8 In countries across the 
world, PLHIV and human rights activists have used 
the law and the courts to challenge discriminatory 
laws and policies in areas such as employment, ed-
ucation, and social services.9 
When UNAIDS was established, it took 
special care to listen to rights activists’ concerns. 
Steps were taken to formally involve activists in 
UNAIDS decision-making processes, such as by 
including civil society representatives as (non-vot-
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ing) members of its Programme Coordinating 
Board. Further, UNAIDS established the Reference 
Group on HIV and Human Rights in 2002 to ad-
vise the agency on human rights issues relevant to 
the response. Civil society representatives were also 
included as (voting) board members of the Global 
Fund to Fight AIDS, Tuberculosis and Malaria; and 
the Global Fund’s board has since worked to better 
integrate human rights issues into country coordi-
nating mechanisms and has made the promotion 
and protection of human rights one of the four 
major objectives of its 2017–2022 strategy.10 Despite 
these positive and pioneering steps, ensuring the 
genuine, inclusive, and meaningful incorporation 
of activists, especially those representing key popu-
lations, into decision making at the United Nations 
level remains an urgent priority.11 Addressing this 
challenge will require organizations leading the 
HIV/AIDS response to redouble engagement with 
activists at this pivotal juncture.
It is thanks to the efforts of activists of all 
stripes that we have, to some extent, seen the 
propagation of a global “norm cascade,” with states 
increasingly promulgating laws to protect the 
rights of PLHIV (although the enforcement of such 
laws remains uneven). In 2014, 64% of countries 
reporting to UNAIDS had laws protecting PLHIV 
from discrimination based on HIV status.12 There 
has also been a rapid reduction in the number of 
countries restricting the entry, stay, or residence 
of PLHIV, falling from 59 to 35 between 2008 and 
2015, demonstrating the speed of improvements in 
legislation to enhance certain rights of PLHIV.13 
Persisting and emerging human rights 
challenges 
Nevertheless, many countries still have laws, 
regulations, and policies hindering effective HIV 
prevention, treatment, care, and support for key 
populations, including MSM, intravenous drug 
users, sex workers, and transgender people. Some 
73 countries, nearly 40% of the global total, crim-
inalize same-sex relations.14 This is in spite of 
the evidence that criminalization and punitive 
laws negatively affect HIV transmission by com-
pounding stigma and creating structural barriers 
to biomedical prevention, health education, and 
engagement with health services.15 For example, 
in Caribbean countries where homosexuality is 
criminalized, 25% of MSM are reported to be in-
fected with HIV, a significantly higher rate than in 
countries that do not criminalize homosexuality.16 
Similarly, HIV prevalence among sex workers is 
generally lower in European countries that have de-
criminalized aspects of sex work than those where 
it is criminalized.17 Alongside evidence from these 
country-comparison studies, the TRUST cohort 
study has demonstrated that Nigeria’s 2014 Same 
Sex Marriage Prohibition Act caused a decrease in 
engagement with HIV services among MSM.18 
These examples serve to remind us that there 
is no guaranteed “march of progress” toward im-
proved rights for PLHIV or key populations at risk, 
despite the continuous accumulation of evidence 
that respecting human rights enhances health. 
Laws protecting and promoting human rights exist 
in an unstable, precarious, and politicized equilib-
rium. For example, in India, home to the world’s 
third-largest HIV epidemic, the high court struck 
down the Criminal Code provision criminalizing 
same-sex sexual relations in 2009 before it was rein-
stated by the Supreme Court in 2013. Today, in 2017, 
new waves of populist nationalism and a reinvigo-
rated backlash against globalization may threaten 
hard-won rights gains. Human rights organizations 
have warned that the postwar international human 
rights system, founded on the Universal Declara-
tion of Human Rights, is at risk from leaders who 
frame human rights as a hindrance to state sover-
eignty or traditional culture.19 We have already seen 
President Trump reinstate and expand the Mexico 
City Policy, or Global Gag Rule, placing restrictions 
on several agencies (including the United States 
President’s Emergency Plan for AIDS Relief) that 
may provide information on abortion. This policy 
is likely to infringe significantly on adolescent girls’ 
and young women’s access to contraception and 
HIV counselling services.20 
Currently, HIV infection rates are rising rap-
idly in countries where there is a limited possibility 
of holding the government to account regarding its 
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human rights commitments. A prime example is 
Russia, where in 2015 in certain cities, one in three 
intravenous drug users was living with HIV.21 Rus-
sia has a legal ban on opioid substitution therapy, 
despite its well-evidenced effectiveness for manag-
ing dependency and preventing HIV. Thus, the ban 
arguably contravenes article 12 (on the right to en-
joy the highest standard of health) and article 15 (on 
the right to enjoy the benefits of scientific progress) 
of the International Covenant on Economic, Social 
and Cultural Rights, despite Russia being a party 
to the convention. Russia’s policies have prompted 
concerns from the United Nations Human Rights 
Committee, but the onus falls on brave activists to 
attempt to redress violations through regional or 
international human rights mechanisms, such as 
the European Court of Human Rights.22 
Despite these numerous challenges, it is im-
portant to highlight recent hard-won successes of 
HIV activists and human rights defenders who 
have advanced the rights of PLHIV through com-
binations of advocacy, activism, and litigation. For 
example, in England in March 2016, the National 
Health Service abandoned plans to roll out pre-ex-
posure prophylaxis (PrEP), arguing that the health 
service was not responsible for preventative health. 
However, after a successful challenge from advoca-
cy organizations such as the National AIDS Trust, 
England’s Court of Appeal ruled in November 2016 
that the National Health Service has the legal power 
to procure and provide PrEP.23 A large, three-year 
implementation trial of PrEP is now set to begin 
in September 2017, providing PrEP to an estimat-
ed 10,000 people at high risk of HIV infection.24 
Moreover, in countries such as Ukraine, activists 
have been a driving force behind AIDS programs 
and continue to keep AIDS in the spotlight amid 
the civil conflict.25 Finally, in Zimbabwe, where na-
tional policies seem to be moving against the tide of 
the expansion of human rights, grassroots activist 
Martha Tholanah has been waging a brave fight 
against HIV-related and LGBT+ stigma, despite re-
cently facing court charges on the basis of running 
an “unregistered” organization.26 
Perhaps the greatest concern for the future of 
the HIV/AIDS response is the largest-ever cohort of 
adolescents, particularly adolescent girls and young 
women, living with HIV in sub-Saharan Africa. 
Deeply entrenched social drivers and structural 
violence—especially inequality and poverty, symp-
toms of what Paul Farmer has termed “pathologies 
of power”—are fueling this epidemic. Vulnerability 
to HIV continues to be socially conditioned in a 
context of gender inequality, intimate partner vio-
lence, and limited economic and social rights (such 
as low education and low levels of socioeconomic 
independence) which undermine women’s ability 
to exercise their sexual and reproductive rights. For 
example, phylogenetic data from recent research in 
KwaZulu-Natal, South Africa, shows that age-dis-
parate sex (sex between women under 25 and men 
on average 8.7 years older), in a context of patriarchy 
and unequal gender power relations, is a significant 
driver of the epidemic.27 
In countries such as South Africa, the pro-
motion of equality and prevention of unfair 
discrimination are enshrined in the constitution; 
however, legal protections for civil and political 
rights mean little to those who are not in a suffi-
ciently secure socioeconomic situation to exert 
those rights.28 In such contexts, human rights ap-
proaches that reduce discrimination, stigma, and 
marginalization must also advance social and 
economic equality and justice, recognizing that 
poverty and inequality expose individuals to vio-
lations of their civil and political rights and thus 
negatively affect HIV transmission patterns.
The continuing imperative for integrating 
human rights into HIV/AIDS and global 
health efforts
Even if the future of the HIV/AIDS response is at 
risk in the current political climate, the centrality 
of human rights in HIV/AIDS provides a model for 
other areas of global health. For example, the fact 
that antiretroviral therapy was initially rolled out in 
the face of skepticism and pessimism but has today 
reached more than 19.5 million people, according to 
UNAIDS, has inspired advocates in other disease 
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areas to campaign for more affordable, equitable 
access to treatment.29 The prominence of rights in 
the HIV/AIDS response will continue to provide 
lessons and precedents for our response to other ep-
idemics and evolving health threats. For example, a 
lawsuit before Brazil’s Supreme Court requesting 
access to information, health services, and safe 
abortion for victims of Zika builds on the model of 
litigating the right to health in the context of AIDS 
in Brazil and many other Latin American coun-
tries.30 In addition, the 2013–2016 Ebola outbreak 
in West Africa brought human rights concerns to 
the fore, as quarantine and coercive measures were 
used during the outbreak in a climate of poor mes-
saging, limited treatments, and social and political 
instability. Today, survivors face stigma, and learn-
ing from the HIV/AIDS pandemic may help ensure 
that they remain free from discrimination as they 
reintegrate into community life.31 
Looking forward within the field of HIV and 
human rights, we increasingly find that legislation 
is in place but that individuals who might use the 
law to fulfill their rights do not have the resources, 
power, or sense of personal security and safety to 
do so. This is in the context of a “shrinking civil 
society space” that limits the ability of human 
rights organizations and defenders to operate, ad-
vance rights- and evidence-based responses, and 
advocate for political, economic, and social change. 
In a global climate that appears increasingly hos-
tile—or at least indifferent—to human rights, and 
where competing priorities have a significant im-
pact on AIDS funding, there are challenges ahead 
in terms of supporting rights-based advocacy and 
activism for HIV/AIDS.32 In the context of HIV/
AIDS, a bold defense of human rights can make the 
difference between life and death for entire groups 
of vulnerable people, as seen in the expansion of 
(and continuing gaps in access to) life-saving an-
tiretroviral drugs. Limited resources and political 
instability across the world pose serious challenges, 
but we must do more to support rights-based ap-
proaches if we are to make good on our pledge to 
reduce new HIV infections and end AIDS without 
leaving anyone behind.
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